Justine Lei

CMS Continues To Plan AHEAD Amid Rising Healthcare Costs

CMS Issues CY2025 Medicare Advantage And Part D Final Rule

FDA Issues Final Rule And Guidance On Direct-To-Consumer Prescription Drug Advertisements

CMS Promotes Competition, Transparency, Health Equity And More In The CY2025 Medicare Advantage And Part D Proposed Rule

From Good Reprint Practices To SIUU Communications: What Firms Need To Know

Connecticut Follows In The Footsteps Of Other Jurisdictions Requiring Registration Of Pharmaceutical Representatives

Context Is Key: FDA Sends A Strong Message About Efficacy Claims

DOJ Continues To Discuss Updates To Compliance Program Guidance And Corporate Enforcement Policies

FDA Approval Mifepristone REMS Program Modification Expands Patient Access To Abortion Care

Digital Health: Significant FDA Policy Developments In 2022

Long Term Care Update: As Winter Arrives, CMS Renews Its Emphasis On COVID-19 Vaccinations, Bivalent Boosters And Timely Therapeutic Treatments

Supreme Court Decision In Dobbs v. Jackson Women's Health Organization Overturns 50 Years Of Precedent On Abortion Laws And Rights